Travere Therapeutics Inc

Healthcare · Biotechnology

52.10$ +0.2% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

Travere Therapeutics Inc (TVTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 799 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TVTX
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	532	525	510	507	521	520	501	491	716	709	668	648	614	605	573	679	692	607	764	747	775	777	828	779	726	673	808	736	833	789	664	551	504	594	549	555	539	605	555	799
Current Assets	343	332	322	320	325	326	287	279	503	496	476	457	440	429	407	506	498	410	565	550	579	583	631	587	535	486	605	542	686	617	481	369	325	417	374	380	371	438	393	615
Cash	24	41	42	89	99	99	61	89	155	103	70	76	65	62	67	237	200	85	148	83	150	166	257	180	151	62	161	71	144	58	43	32	36	59	62	75	111	93	78	118
Cash & Short-Term Investments	274	256	248	296	304	301	264	256	479	472	448	426	407	399	356	457	456	362	521	523	551	553	603	553	506	450	562	491	635	567	441	325	277	371	322	320	255	323	265	489
Receivables	61	65	63	13	15	14	13	12	13	14	13	15	17	18	38	34	15	33	30	12	14	16	15	17	13	17	24	20	15	21	23	24	25	27	34	39	83	81	87	81
Inventory	3.3	2.8	4.8	4.4	4.3	5.4	5.1	5.4	5.1	5.6	5.6	5.1	5.3	6.1	6.6	6.3	7.3	7.6	7.2	7.4	6.6	7.3	6.5	7.6	7.3	4.5	6.7	19	21	9.4	4.5	6.0	6.4	6.2	3.9	4.1	5.5	5.9	6.4	7.8
Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	9.8	32	35	37	36	12	11	11	10	9.6	9.0	9.1	8.6	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.9	0.8	0.9	0.9	0.8	0.8	0.8	0.8	0.7	0.8	0.8	0.8	0.8	0.8	0.8	–
Intangible Assets	183	182	181	180	180	185	189	187	187	187	160	159	158	157	156	155	154	153	151	150	149	147	152	149	149	96	162	154	106	104	100	104	103	103	103	105	109	113	109	132
Total Liabilities	225	218	209	211	216	227	201	203	397	391	382	370	368	384	347	360	391	396	401	414	468	475	620	623	626	630	619	620	553	588	589	536	535	535	516	523	465	490	456	775
Current Liabilities	86	83	77	80	84	86	57	103	100	105	104	91	88	95	68	70	75	93	85	97	113	124	119	124	131	142	131	136	139	178	173	121	190	201	182	190	135	160	125	152
Short-Term Debt	–	27	–	–	–	–	–	45	22	22	23	–	–	–	–	–	0.8	492	1.1	2.6	63	3.9	4.0	4.1	4.2	4.4	4.5	4.7	4.8	4.9	5.0	5.2	74	74	74	74	5.7	5.9	6.0	6.2
Accounts Payable	3.1	7.5	4.7	9.1	7.4	19	9.4	7.8	9.3	7.0	7.6	13	14	27	10.0	10	9.4	12	15	8.3	5.8	15	18	12	14	17	17	20	25	42	17	26	23	24	15	19	18	25	13	7.5
Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	207	210	213	215	218	221	224	227	374	375	375	376	376	376	377	377	378	378	310	310	311	311	311	312	312	603
Shareholders' Equity	308	308	301	296	305	293	299	288	319	318	286	277	246	221	226	319	301	211	363	332	307	302	208	157	101	43	189	116	280	201	74	15	-30	59	33	33	74	115	99	25
Retained Earnings	-104	-113	-129	-142	-160	-178	-186	-208	-263	-270	-311	-350	-386	-416	-416	-442	-464	-586	-640	-679	-714	-766	-812	-879	-948	-1,014	-1,101	-1,186	-1,035	-1,126	-1,262	-1,332	-1,387	-1,447	-1,488	-1,501	-1,475	-1,473	-1,510	-1,545
Shares Outstanding	37	39	39	39	39	40	40	40	41	41	41	42	43	44	44	45	51	51	56	61	61	62	63	64	64	64	68	76	76	76	77	78	78	83	88	89	103	90	92	93

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings